CHI3L1 and Alzheimer disease: Therefore, although the results of the current meta-analysis suggest the combined effect of YKL-40 in peripheral blood does not appear to be significantly different in identifying patients with AD and HCs, the finding is likely to be less reliable and additional studies are required to substantiate it in the future.